NeuClone’s Trastuzumab Trial Succeeds

Reports Successful Phase I Trial For NeuCeptin Trastuzumab Biosimilar

 
• By Akriti Seth
  
Compass_Success
NeuClone and partner Serum Institute of India have reported success in a phase I trial for trastuzumab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products